Reuters logo
BRIEF-‍Anthem issues a positive coverage decision for NanoString’s Prosigna
September 5, 2017 / 10:26 AM / 21 days ago

BRIEF-‍Anthem issues a positive coverage decision for NanoString’s Prosigna

Sept 5 (Reuters) - Anthem Inc

* ‍Anthem has issued a positive coverage decision for Nanostring’s Prosigna breast cancer gene signature assay​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below